Biotech

All Articles

ArsenalBio raises $325M, pivots off of former lead possession

.Collection Biosciences is going on up. The tissue therapy firm has actually added on $325 million i...

Lilly- supported weight-loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis usage drug flunks period 2b, steering Indivior to reconsider $100M option

.Aelis Farma's hopes of getting a quick, favorable selection on a $one hundred thousand option payme...

ProKidney halts stage 3 trial not required for cell therapy permission

.ProKidney has actually ceased one of a set of phase 3 tests for its own tissue therapy for kidney h...

Vaxcyte climbs on 'impressive' 31-valent PCV succeed versus Pfizer

.Vaxcyte introduced what professionals called "magnificent" phase 1/2 data for its own 31-valent pne...

Recursion's mind illness test reveals little evidence of effectiveness

.Recursion has actually discovered with a very early exam of its tech-enabled method to medicine dis...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Contact it a case of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winning...

Praxis epilepsy medication minimizes confiscations in phase 2 hearing

.Practice Accuracy Medicines has actually racked up another midphase win in epilepsy this year, with...

Three execs resign as Dyne messages blended data for DMD candidate

.After leaving a scientific hold many years back, Dyne Therapeutics has exposed brand-new stage 1/2 ...

Arrowhead fires off period 3 data in uncommon metabolic condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand in advance of a prospective face-off along with Io...